2023年多发性骨髓瘤的方式:从试验到现实生活
Manlio Fazio1, Vittorio Del Fabro2, Nunziatina Laura Parrinello2
1Post-Graduation School of Haematology, University of Catania, A.O.U. 'Policlinico-San Marco', 95123 Catania, Italy.
Current oncology (Toronto, Ont.)
|November 24, 2023
概括
多发性骨髓瘤治疗正在进步,新的药物来自临床试验和现实世界的数据. 像CAR-T细胞这样有前途的疗法为晚期多发性骨髓瘤患者提供了希望.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 多发性髓瘤是一种复发性血液性恶性瘤.
- 分子理解的进步推动了新药的开发.
- 新疗法需要结合临床试验和现实世界的数据.
研究的目的:
- 审查当前多发性骨髓瘤治疗方案.
- 将临床试验数据与真实世界患者体验进行比较.
- 为突出针对晚期疾病的新兴疗法.
主要方法:
- 临床试验文献综述.临床试验的文献综述.
- 对多发性骨髓瘤治疗的现实数据的分析.
- 对新型治疗策略的评估.
主要成果:
- 新药被批准并纳入治疗.
- 临床试验与现实世界结果之间存在差异.
- T细胞参与者和CAR-T细胞在晚期阶段显示有效性.
结论:
- 整合临床试验和现实世界的数据对于优化多发性骨髓瘤治疗至关重要.
- 像CAR-T细胞这样的新型免疫疗法代表了重大进步.
- 需要继续进行研究,以完善复发性多发性骨髓瘤的治疗策略.
关键词:
卡特-T细胞治疗疗法自体干细胞移植自体干细胞移植两种特定抗原的抗原.在达拉图姆巴姆巴布.脆弱 脆弱 脆弱 脆弱 脆弱最少残留疾病的最小残留疾病.多发性骨髓瘤是多发性骨髓瘤的一种.现实生活中的现实生活.复发-耐药性疾病复发-耐药性疾病测序的测序是指测序的测序.护理的标准 护理的标准更多相关视频
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019
6.9K
07:24Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
6.5K
相关概念视频
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...